Literature DB >> 33393621

Circ_0061012 contributes to IL-22-induced proliferation, migration and invasion in keratinocytes through miR-194-5p/GAB1 axis in psoriasis.

Qi He1, Nian Liu2, Feng Hu3, Quan Shi1, Xianming Pi1, Hongxiang Chen2, Jiawen Li2, Bo Zhang1.   

Abstract

Psoriasis is a chronic inflammation-associated skin disorder featured by excessive proliferation and abnormal differentiation of keratinocytes. Here, we intended to investigate the role of circular RNA 0061012 (circ_0061012) in psoriasis progression. The expression of circ_0061012, SLMO2-ATP5E readthrough (SLMO2-ATP5E) messenger RNA (mRNA), microRNA-194-5p (miR-194-5p) and GRB2 associated binding protein 1 (GAB1) mRNA was determined by quantitative real-time polymerase chain reaction (qRT-PCR). Cell proliferation and metastasis were analyzed by 3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay and transwell assays. Western blot assay was used to measure the protein levels of Ki67, matrix metallopeptidase 9 (MMP9) and GAB1. Dual-luciferase reporter assay and RNA immune co-precipitation (RIP) assay were used to verify the interaction between miR-194-5p and circ_0061012 or GAB1. Circ_0061012 abundance was significantly enhanced in lesional skin samples from psoriasis patients than that in normal skin specimens from healthy volunteers. Interleukin-22 (IL-22) treatment increased the expression of circ_0061012 in a dose-dependent manner. Circ_0061012 silencing alleviated IL-22-induced promoting effects in the proliferation, migration and invasion of HaCaT cells. Circ_0061012 interacted with miR-194-5p, and miR-194-5p knockdown counteracted circ_0061012 silencing-mediated influences in IL-22-induced HaCaT cells. GAB1 was a target of miR-194-5p in HaCaT cells, and miR-194-5p hampered proliferation and metastasis which were induced by IL-22 partly through targeting GAB1. Circ_0061012 elevated the expression of GAB1 through sponging miR-194-5p in HaCaT cells. Circ_0061012 accelerated IL-22-induced proliferation and metastasis in HaCaT cells through enhancing GAB1 expression via sponging miR-194-5p in psoriasis.
© 2021 The Author(s).

Entities:  

Keywords:  GAB1; IL-22; circ_0061012; miR-194-5p; psoriasis

Mesh:

Substances:

Year:  2021        PMID: 33393621      PMCID: PMC7809556          DOI: 10.1042/BSR20203130

Source DB:  PubMed          Journal:  Biosci Rep        ISSN: 0144-8463            Impact factor:   3.840


  28 in total

1.  Serum IL-22 correlates with psoriatic severity and serum IL-6 correlates with susceptibility to phototherapy.

Authors:  Yuan-Hsin Lo; Kan Torii; Chiyo Saito; Takuya Furuhashi; Akira Maeda; Akimichi Morita
Journal:  J Dermatol Sci       Date:  2010-04-03       Impact factor: 4.563

Review 2.  Immunopathogenesis of psoriasis.

Authors:  Brian J Nickoloff; Jian-Zhong Qin; Frank O Nestle
Journal:  Clin Rev Allergy Immunol       Date:  2007-10       Impact factor: 8.667

3.  MiR-194-5p inhibits cell migration and invasion in bladder cancer by targeting E2F3.

Authors:  Yanmei Wang; Guiying Sun; Chenghong Wang; Wenchen Guo; Qianqing Tang; Meng Wang
Journal:  J BUON       Date:  2018 Sep-Oct       Impact factor: 2.533

4.  MicroRNA-194 regulates keratinocyte proliferation and differentiation by targeting Grainyhead-like 2 in psoriasis.

Authors:  Xiaoyun Yu; Jingang An; Yunhui Hua; Zihai Li; Ning Yan; Weixin Fan; Chuan Su
Journal:  Pathol Res Pract       Date:  2016-12-19       Impact factor: 3.250

5.  miR-424 levels in hair shaft are increased in psoriatic patients.

Authors:  Yasuo Tsuru; Masatoshi Jinnin; Asako Ichihara; Akihiko Fujisawa; Chikako Moriya; Keisuke Sakai; Satoshi Fukushima; Hironobu Ihn
Journal:  J Dermatol       Date:  2014-03-15       Impact factor: 4.005

6.  A disease module in the interactome explains disease heterogeneity, drug response and captures novel pathways and genes in asthma.

Authors:  Amitabh Sharma; Jörg Menche; C Chris Huang; Tatiana Ort; Xiaobo Zhou; Maksim Kitsak; Nidhi Sahni; Derek Thibault; Linh Voung; Feng Guo; Susan Dina Ghiassian; Natali Gulbahce; Frédéric Baribaud; Joel Tocker; Radu Dobrin; Elliot Barnathan; Hao Liu; Reynold A Panettieri; Kelan G Tantisira; Weiliang Qiu; Benjamin A Raby; Edwin K Silverman; Marc Vidal; Scott T Weiss; Albert-László Barabási
Journal:  Hum Mol Genet       Date:  2015-01-12       Impact factor: 6.150

7.  Circular RNA Expression Profile and Analysis of Their Potential Function in Psoriasis.

Authors:  Meng Qiao; Jian Ding; Jianjun Yan; Ronghua Li; Jian Jiao; Qing Sun
Journal:  Cell Physiol Biochem       Date:  2018-10-02

Review 8.  microRNAs in Psoriasis.

Authors:  Jason E Hawkes; Giang Huong Nguyen; Mayumi Fujita; Scott R Florell; Kristina Callis Duffin; Gerald G Krueger; Ryan M O'Connell
Journal:  J Invest Dermatol       Date:  2016-02       Impact factor: 8.551

9.  MiR-194-5p inhibited metastasis and EMT of nephroblastoma cells through targeting Crk.

Authors:  Hong Liu; Shi-Ying Ren; Yan Qu; Cui Liu; Yi Zhang; Xiang Qing Li; Hong Ma
Journal:  Kaohsiung J Med Sci       Date:  2019-12-31       Impact factor: 2.744

Review 10.  Interplay between keratinocytes and immune cells--recent insights into psoriasis pathogenesis.

Authors:  Giulia Tonel; Curdin Conrad
Journal:  Int J Biochem Cell Biol       Date:  2008-11-05       Impact factor: 5.085

View more
  3 in total

1.  microRNA-194 is increased in polycystic ovary syndrome granulosa cell and induce KGN cells apoptosis by direct targeting heparin-binding EGF-like growth factor.

Authors:  Yi-Xuan Wu; Yan-Shan Lin; Si-Chen Li; Xi Yao; Mingwei Cheng; Lin Zhu; Hai-Ying Liu
Journal:  Reprod Biol Endocrinol       Date:  2021-11-23       Impact factor: 5.211

2.  MicroRNA Alterations Induced in Human Skin by Diesel Fumes, Ozone, and UV Radiation.

Authors:  Giuseppe Valacchi; Erika Pambianchi; Simona Coco; Alessandra Pulliero; Alberto Izzotti
Journal:  J Pers Med       Date:  2022-01-28

Review 3.  circRNA: Regulatory factors and potential therapeutic targets in inflammatory dermatoses.

Authors:  Ruifeng Liu; Luyao Zhang; Xincheng Zhao; Jia Liu; Wenjuan Chang; Ling Zhou; Kaiming Zhang
Journal:  J Cell Mol Med       Date:  2022-06-29       Impact factor: 5.295

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.